P186D

Please rate the extent to which this activity met the following objectives:

1 = poor, 2 = fair, 3 = good, 4 = very good, 5 = excellent

Review NTM-LD pathophysiology associated patient risk factors/signs/symptoms, underlying conditions including bronchiectasis, and strategies for early and accurate diagnosis

	1	2	3	4	5

1 is Poor, 5 is Excellent

Analyze clinical trial data of amikacin-based inhalation therapeutics for the treatment of NTM- LD

	1	2	3	4	5

1 is Poor, 5 is Excellent

Develop guideline-driven individualized treatment plans coordinating anti-microbial therapy with respiratory therapy to improve outcomes for patients with NTM-LD

	1	2	3	4	5

1 is Poor, 5 is Excellent

Please provide feedback regarding your experience with this activity:

1 = poor, 2 = fair, 3 = good, 4 = very good, 5 = excellent

Overall

	1	2	3	4	5

1 is Poor, 5 is Excellent

Content

	1	2	3	4	5

1 is Poor, 5 is Excellent

Usefulness

	1	2	3	4	5

1 is Poor, 5 is Excellent

YesNo

If no, please explain:

YesNoN/A

I gained new strategies/skills/information that my team can apply to practiceI plan to implement new strategies/skills/information in my practiceI will be more competent in my team’s management of patient careI will improve my communication with the healthcare team

What factors beyond clinical care that effect the health of your patients does your team experience?